首页 正文

VSIG2 Promotes Osteosarcoma Cisplatin Resistance Via Activating PI3K/AKT/mTOR Pathway

{{output}}
Introduction: Chemotherapy resistance is one of the main reasons for osteosarcoma (OS) relapses. Understanding the regulatory mechanisms of cisplatin resistance is critical for developing potential therapeutic strategies for OS. ... ...